12 Nov 2025
// PR NEWSWIRE
30 Oct 2025
// INDPHARMAPOST
30 Oct 2025
// PR NEWSWIRE
Latest Content by PharmaCompass
Reset all filters
01 2ACITRETIN
02 3ASENAPINE MALEATE
03 2ASPIRIN; BUTALBITAL; CAFFEINE
04 1ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
05 2Atropine
06 1BEZAFIBRATE
07 2BRIMONIDINE TARTRATE
08 5Bimatoprost
09 1Bismuth Subcitrate Potassium; Metronidazole; Tetracycline Hydrochloride
10 1Brimonidine Tartrate
11 1Brimonidine Tartrate; Timolol
12 2CHLORAMPHENICOL
13 1CHLORAMPHENICOL; PREDNISOLONE
14 1CROMOLYN SODIUM
15 1CYCLOSPORINE
16 1Carmelose Sodium
17 1Cyclopentolate
18 1DEXAMETHASONE
19 2DICYCLOMINE HYDROCHLORIDE
20 3DILTIAZEM HYDROCHLORIDE
21 1DIPIVEFRIN HYDROCHLORIDE
22 3Dexamethasone
23 1EPINASTINE HYDROCHLORIDE
24 1ESTRADIOL
25 4ETHINYL ESTRADIOL; NORETHINDRONE
26 1ETHOXZOLAMIDE
27 2Eluxadolin
28 2Eluxadoline
29 1Epinastine
30 4FLUOCINOLONE ACETONIDE
31 1FLUOROMETHOLONE
32 1FLUOROMETHOLONE; SULFACETAMIDE SODIUM
33 1FLURBIPROFEN SODIUM
34 1Flurbiprofen
35 1GATIFLOXACIN
36 1GENTAMICIN SULFATE
37 2GENTAMICIN SULFATE; PREDNISOLONE ACETATE
38 5HYDROCORTISONE
39 2HYDROXYPROGESTERONE CAPROATE
40 1IDOXURIDINE
41 1IRON DEXTRAN
42 1KETOROLAC TROMETHAMINE
43 2Ketorolac Tromethamine
44 1Ketorolaco Trometamol
45 2LEVOBUNOLOL HYDROCHLORIDE
46 6LIOTRIX (T4;T3)
47 3Levobunolol
48 2Levobunolol hydrochloride
49 1MEDRYSONE
50 1MEMANTINE HYDROCHLORIDE
51 12MORPHINE SULFATE
52 1NAPHAZOLINE HYDROCHLORIDE
53 4NEBIVOLOL HYDROCHLORIDE
54 1NEDOCROMIL SODIUM
55 1NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PREDNISOLONE ACETATE
56 1OFLOXACIN
57 2OXYBUTYNIN
58 2Ofloxacin
59 5OnabotulinumtoxinA
60 1PHENYLEPHRINE HYDROCHLORIDE; PYRILAMINE MALEATE
61 1PODOFILOX
62 1POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE
63 2PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM
64 1PROPARACAINE HYDROCHLORIDE
65 4Pancreas Powder
66 2Pilocarpine
67 1SELENIUM SULFIDE
68 3SULFACETAMIDE SODIUM
69 2Sodium Carmellose
70 2TRETINOIN
71 1TRIAMCINOLONE ACETONIDE
72 3TRIMEPRAZINE TARTRATE
73 2TROSPIUM CHLORIDE
74 2Tazaroten
75 4Tazarotene
76 1Timolol Maleate; Brimonidine
77 2Timolol; Bimatoprost
78 1Timolol; Brimonidine
79 1pirenoxine
Reset all filters
01 91ALLERGAN
02 14ALLERGAN HERBERT
03 3ALLERGAN INC
04 1ALLERGAN PHARMACEUT.INTERN.LTD
05 8ALLERGAN PHARMACEUTIC.IRELAND
06 14ALLERGAN SpA
07 1Allergan France
08 1Allergan Limited
09 4Allergan Pharmaceuticals (Pty) Ltd
10 4Allergan Pharmaceuticals International Limited
11 6Allergan Pharmaceuticals International Ltd
12 9Allergan Pharmaceuticals Ireland
Reset all filters
01 2AEROSOL;TOPICAL
02 1Bimatoprost 0,3Mg/Ml 0.4 Ml 30Units Solution Ophthalmic Use
03 1Bimatoprost 0,3Mg/Ml 3Ml Solution Ophthalmic Use
04 1Bimatoprost 0.1Mg/Ml 3Ml Solution Ophthalmic Use
05 1Bismuth Oxide+Metronidazole+Tetracycline Hydrochloride 140+125+125Mg 120 Unita' Oral Use
06 1Brimonidine 0.2% 5Ml Solution Ophthalmic Use
07 2CAPSULE
08 17CAPSULE, EXTENDED RELEASE;ORAL
09 3CAPSULE;ORAL
10 4CREAM;TOPICAL
11 1CREAM;VAGINAL
12 4Capsule
13 1Dexamethasone 700Mcg 1 Units Use Intravitreale
14 1EMULSION; OPHTHALMIC
15 3Eye Drop
16 2Eye Drop In Solution In Single-Dose Container
17 3Eye Drop Solution
18 1FILM, EXTENDED RELEASE;TRANSDERMAL
19 4Film Coated Tablet
20 2GEL
21 1GEL, METERED;TRANSDERMAL
22 3GEL;TOPICAL
23 4Gel
24 3INJECTABLE;INJECTION
25 1INJECTABLE;INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL
26 1LOTION/SHAMPOO;TOPICAL
27 1Levobunolol 0.5% 0.4 Ml 60 Units Solution Ophthalmic Use
28 1Levobunolol 0.5% 5Ml Solution Ophthalmic Use
29 6OINTMENT;OPHTHALMIC
30 2OINTMENT;TOPICAL
31 2OPD
32 21SOLUTION/DROPS;OPHTHALMIC
33 1SOLUTION;ORAL
34 2SOLUTION;TOPICAL
35 3SUSPENSION/DROPS;OPHTHALMIC
36 2SUSPENSION;OPHTHALMIC
37 1SYRUP;ORAL
38 1Solution
39 1TABLET (EXTENDED-RELEASE)
40 15TABLET;ORAL
41 2TABLET;ORAL-21
42 2TABLET;ORAL-28
43 3TABLET;SUBLINGUAL
44 1Timolol+Bimatoprost 300Mcg/Ml+5Mg/Ml 30 Joined' Solution Ophthalmic Use
45 1Timolol+Bimatoprost 900Mcg+15Mg Solution Ophthalmic Use
46 1Timolol+Bromonidine 0.2%+0.5% 5Ml Solution Ophthalmic Use
47 5VIAL; SINGLE-USE
48 14Blank
Reset all filters
01 10.0005
02 20.01%
03 10.01% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
04 10.0125MG;0.0031MG
05 30.025%
06 10.025MG;0.0063MG
07 10.03% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
08 20.035MG;0.5MG
09 20.035MG;1MG
10 10.0375%
11 20.05%
12 10.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
13 10.05MG;0.0125MG
14 10.075%
15 40.1%
16 10.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
17 10.1%;10%
18 10.10%
19 10.12%;0.1%
20 10.15MG;0.0375MG
21 10.1MG
22 10.1MG;0.025MG
23 10.2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
24 20.2%;10%
25 10.25% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
26 10.25MG;0.0625MG
27 10.3%
28 10.3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
29 10.3MG
30 60.5%
31 10.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
32 51%
33 11%;0.5%
34 210%
35 110,000 UNITS/ML;EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
36 2100 UNITS/VIAL
37 110000U
38 2100MG
39 1100mg
40 210MG
41 110MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
42 1120 cps 140 mg + 125 mg + 125 mg
43 1120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
44 1125MG
45 1125MG/ML
46 1130MG
47 1150MG
48 1180MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
49 11mg/g
50 12% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
51 22.5%
52 1200 UNITS/VIAL
53 1200MG
54 120MG
55 220MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
56 1240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
57 125000U
58 1250MG/ML
59 125MG
60 12MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
61 12MG/ML; 5MG/ML
62 12MG; 5 MG
63 13%
64 13.9MG/24HR
65 130%
66 130MG
67 2325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
68 1325MG;50MG;40MG;30MG
69 14% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
70 140 Monod Coll 0.4 Ml 0.03%
71 140000U
72 1400MG
73 140MG
74 250 UNITS/VIAL
75 15000U
76 150MG
77 15MG
78 15MG/ML
79 55mg/ml
80 160MG
81 160MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
82 170MG
83 175MG
84 175mg
85 180MG
86 18MG/0.1ML (8MG/0.1ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
87 1Coll 10 Ml 0.3%
88 1Coll 10 Ml 0.5%
89 2Coll 10 Ml 1%
90 1Coll 10 Ml 2%
91 1Coll 3 Ml 0.2%
92 1Coll 3 Ml 1%
93 1Coll 5 Ml 0,5 Mg/Ml
94 1Coll 5 Ml 0.1%
95 1Coll 5 Ml 0.5%
96 1Coll Bottle Groun 0.005% + Plug Solv 7 Ml
97 1EQ 0.3% BASE
98 1EQ 0.3% BASE;0.6%
99 1EQ 0.3% BASE;1%
100 1EQ 0.35% BASE;10,000 UNITS/ML;0.5%
101 1EQ 100MG IRON/2ML (EQ 50MG IRON/ML)
102 2EQ 10MG BASE
103 3EQ 2.5MG BASE
104 1EQ 2.5MG BASE/5ML
105 1EQ 20MG BASE
106 3EQ 5MG BASE
107 1EYE DROPS 3 ML 300 mcg/ml + 5 mg/ml
108 1EYE DROPS 3 ml 0,3 mg/ml
109 1EYE DROPS 3 ml 0. 1 mg/ml
110 1EYE DROPS 5 ml 0.2% + 0.5%
111 1EYE DROPS 5 ml 2 mg/ml
112 1EYE DROPS 5 ml 5 mg/ml
113 1Pom Oftalm 3,5 G 0,3%
114 1Ung Oftalm 3 G 0,2%
115 1collyrium 30 monodose containers 0.4 ml 300 mcg/ml + 5 mg/ml
116 1collyrium 30 monodose vials 0.4 ml 0,3 mg/ml
117 1collyrium 60 monodose vials 0.4 ml 5 mg/ml
118 1intravitreale implant 700 mcg + applicator
119 1Blank
Reset all filters
01 3Canada
02 25Italy
03 2Malta
04 4South Africa
05 9Spain
06 10Sweden
07 103USA
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : CAPSULE
Brand Name : SORIATANE
Dosage Strength : 25MG
Packaging : 30
Approval Date :
Application Number : 2070863
Regulatory Info : Prescription
Registration Country : Canada
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : CAPSULE
Brand Name : SORIATANE
Dosage Strength : 10MG
Packaging : 30
Approval Date :
Application Number : 2070847
Regulatory Info : Prescription
Registration Country : Canada
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;SUBLINGUAL
Brand Name : SAPHRIS
Dosage Strength : EQ 5MG BASE
Packaging :
Approval Date : 2009-08-13
Application Number : 22117
Regulatory Info : RX
Registration Country : USA
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;SUBLINGUAL
Brand Name : SAPHRIS
Dosage Strength : EQ 10MG BASE
Packaging :
Approval Date : 2009-08-13
Application Number : 22117
Regulatory Info : RX
Registration Country : USA
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;SUBLINGUAL
Brand Name : SAPHRIS
Dosage Strength : EQ 2.5MG BASE
Packaging :
Approval Date : 2015-03-12
Application Number : 22117
Regulatory Info : RX
Registration Country : USA
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : FIORINAL
Dosage Strength : 325MG;50MG;40MG **Fede...
Packaging :
Approval Date : 1986-04-16
Application Number : 17534
Regulatory Info : DISCN
Registration Country : USA
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : CAPSULE;ORAL
Brand Name : FIORINAL
Dosage Strength : 325MG;50MG;40MG **Fede...
Packaging :
Approval Date : 1986-04-16
Application Number : 17534
Regulatory Info : DISCN
Registration Country : USA
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : DISCN
Registration Country : USA
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Brand Name : FIORINAL W/CODEINE
Dosage Strength : 325MG;50MG;40MG;30MG
Packaging :
Approval Date : 1990-10-26
Application Number : 19429
Regulatory Info : DISCN
Registration Country : USA
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Italy
Dosage Form :
Brand Name : Atropine Lux
Dosage Strength : Coll 10 Ml 0.5% ...
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Italy
Dosage Form :
Brand Name : Atropine Lux
Dosage Strength : Coll 10 Ml 1% ...
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Allergan Aesthetics is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of Botulinum toxin type A bulk offered by Allergan Aesthetics